Treatment for mitochondrial disorders (Q24244543)

Cochrane Database of Systematic Reviews

Europe PubMed Central

title

Treatment for mitochondrial disorders (English)

0 references

1 reference

David Thorburn

4

0 references

author name string

PF Chinnery

series ordinal

1

0 references

Kari Majamaa

series ordinal

2

0 references

Douglas Turnbull

series ordinal

3

0 references

language of work or name

English

0 references

publication date

25 January 2006

0 references

published in

0 references

page(s)

CD004426

0 references

issue

1

0 references

cites work

A placebo-controlled crossover trial of creatine in mitochondrial diseases

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

The effect of short-term dimethylglycine treatment on oxygen consumption in cytochrome oxidase deficiency: a double-blind randomized crossover clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Clinical and brain bioenergetics improvement with idebenone in a patient with Leber's hereditary optic neuropathy: a clinical and 31P-MRS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: results of a 6-month therapy study with coenzyme Q.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Effectiveness of creatine monohydrate in mitochondrial encephalomyopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Sequence and organization of the human mitochondrial genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Chronic treatment of mitochondrial disease patients with dichloroacetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Clinical features, investigation, and management of patients with defects of mitochondrial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Genetic counseling and prenatal diagnosis for mtDNA disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Epidemiology and treatment of mitochondrial disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Getting to the nucleus of mitochondrial disorders: identification of respiratory chain-enzyme genes causing Leigh syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Nuclear power and mitochondrial disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Mitochondrial DNA mutations in human disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

31P NMR study of improvement in oxidative phosphorylation by vitamins K3 and C in a patient with a defect in electron transport at complex III in skeletal muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Role of adenine nucleotide translocator 1 in mtDNA maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

L-arginine improves the symptoms of strokelike episodes in MELAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Therapy of complex I deficiency: peripheral neuropathy during dichloroacetate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Mutations of mitochondrial DNA polymerase gammaA are a frequent cause of autosomal dominant or recessive progressive external ophthalmoplegia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Mitochondrial respiratory chain disorders I: mitochondrial DNA defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Remission of Leber's hereditary optic neuropathy with idebenone

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Do idebenone and vitamin therapy shorten the time to achieve visual recovery in Leber hereditary optic neuropathy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Identification of a gene causing human cytochrome c oxidase deficiency by integrative genomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns-Sayre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Dichloroacetate treatment for mitochondrial cytopathy: long-term effects in MELAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Respiratory chain complex III [correction of complex] in deficiency with pruritus: a novel vitamin responsive clinical feature

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Familial cerebellar ataxia with muscle coenzyme Q10 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

POLG mutations associated with Alpers' syndrome and mitochondrial DNA depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Muscle coenzyme Q deficiency in familial mitochondrial encephalomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Successful treatment with succinate in a patient with MELAS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Effect of high-dose vitamins, coenzyme Q and high-fat diet in paediatric patients with mitochondrial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

MELAS syndrome with mitochondrial tRNA(Leu)(UUR) mutation: correlation of clinical state, nerve conduction, and muscle 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Ubiquinone and nicotinamide treatment of patients with the 3243A-->G mtDNA mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Quinone-responsive multiple respiratory-chain dysfunction due to widespread coenzyme Q10 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Mitochondrial DNA mutations and pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Spontaneous Kearns-Sayre/chronic external ophthalmoplegia plus syndrome associated with a mitochondrial DNA deletion: a slip-replication model and metabolic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Minimum birth prevalence of mitochondrial respiratory chain disorders in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Human mitochondrial DNA deletions associated with mutations in the gene encoding Twinkle, a phage T7 gene 4-like protein localized in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Creatine monohydrate increases strength in patients with neuromuscular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

In-vitro genetic modification of mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Mitochondrial disorders: genetics, counseling, prenatal diagnosis and reproductive options.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Mitochondrial DNA mutations in diseases of energy metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Mitochondrial diseases in man and mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Deletions of mitochondrial DNA in Kearns-Sayre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Deletions of muscle mitochondrial DNA in patients with mitochondrial myopathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

Correction of increased plasma pyruvate and plasma lactate levels using large doses of thiamine in patients with Kearns-Sayre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

The epidemiology of pathogenic mitochondrial DNA mutations

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Aerobic conditioning in patients with mitochondrial myopathies: physiological, biochemical, and genetic effects

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

A randomized, controlled trial of creatine monohydrate in patients with mitochondrial cytopathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Mitochondrial damage in patients with long-term corticosteroid therapy: development of oculoskeletal symptoms similar to mitochondrial disease

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Treatment of complex I deficiency with riboflavin

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

The influence of coenzyme Q10 on total serum calcium concentration in two patients with kearns-sayre syndrome and hypoparathyroidism

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Metabolic interventions against complex I deficiency in MELAS syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Reversible ophthalmoplegia in CPEO

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

CPEO and carnitine deficiency overlapping in MELAS syndrome.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Coenzyme Q10 treatment in mitochondrial encephalomyopathies. Short-term double-blind, crossover study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Treatment of Kearns-Sayre syndrome with coenzyme Q10

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Fatal metabolic acidosis, hyperglycemia, and coma after steroid therapy for Kearns-Sayre syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

31P NMR spectroscopy and ergometer exercise test as evidence for muscle oxidative performance improvement with coenzyme Q in mitochondrial myopathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Proton MR spectroscopic characterization of differences in regional brain metabolic abnormalities in mitochondrial encephalomyopathies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Short-term dichloroacetate treatment improves indices of cerebral metabolism in patients with mitochondrial disorders

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Mitochondrial encephalomyopathy with coenzyme Q10 deficiency

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021

Mitochondrial encephalomyopathy with corticosteroid dependence

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004426.PUB2

7 January 2021